Pierre Landry, M.D., F.R.C.P.(C), Ph. D., neurophysiologie
Fernand-Seguin Research Centre
Louis-H. Lafontaine Hospital
7401 Hochelaga St.
Montreal, QC,
Canada H1N 3M5
Room : 212
Phone : (514) 251-4015 ext: 3070
Fax.: (514) 251-2617
Research areas
Neuroscience (fundamental track)
Academic profile
Psychiatrist (M.D., CSPQ, FRCPC), Head of the Psychopharmacology Clinic of the L-H Lafontaine Hospital, Ph.D. Neurophysiology, Université Laval, Post-doc, Neuroanatomy, University of Michigan, Post-doc Neurophysiology McGill University
Research interests
Clinical research
· Psychopharmacology and Toxicology
· Psychotropic medications and their secondary effects
· Glutamatergic agents (Glyine, CycloSer) in schizophrenia and PTSD
Recents Publications
Charbonneau, K., & Landry, P. (2008). Leukopenia and Neutropenia After Intoxication With Diphenhydramine (Nytol) During Clozapine Treatment. Journal of Clinical Psychopharmacology, 28(6), 706-707.
Landry, P., Dimitri, E., Tessier, S., & Legare, N. (2008). Efficacy of lipid-lowering medications in patients treated with clozapine - A naturalistic study. Journal of Clinical Psychopharmacology, 28(3), 348-349.
O'Connor, K., Marchand, A., Brousseau, L., Aardema, F., Mainguy, N., Landry, P., et al. (2008). Cognitive-behavioural, pharmacological and psychosocial predictors of outcome during tapered discontinuation of benzodiazepine. Clinical Psychology & Psychotherapy, 15(1), 1-14.
Foldes-Busque, G., Marchand, A., Landry, P.(2007). "L'identification et traitement du trouble panique avec ou sans agoraphobie: Mise à jour." Canadian Family Physician 53(10): 1686-1693.
Landry, P., Côté, P., et al. (2006). "La pharmacothérapie de l'état de stress post-traumatique. Les troubles liés aux évènements traumatiques". In: Guay, J.A.S, Grunberg, F. (eds), "Les troubles liés aux évènements traumatiques". Montréal, Les Presses de l'Université de Montréal.
Stip, E., Anselmo, K., Landry, P., et al. (2006). "Long-Term Treatment with Atypical Antipsychotics and Risk of Weight Gain." Drug Safety 29(6): 550-552.
O'Connor, K., Aardema, F., Landry, P, et al. (2005). "Evaluation of an Inference Based Approach to Treating Obsessive-Compulsive Disorder." Cognitive Behavior Therapy 34(3): 148-163.
Marchand, A., Germain, V., Landry, P. (2004). "Analyse des coûts et de l'efficacité d'une psychothérapie pour le Trouble panique avec agoraphobie versus un traitement combinant la pharmacothérapie et la psychothérapie." Santé Mentale au Québec 29(2): 201-220.
O'Connor, K., A. Marchand, Landry, P., et al. (2004). "Psychological Distress and Adaptational Problems Associated with Nenzodiazepine Withdrawal and Outcome: A Replication." Addictive Behaviors 29(3): 583-593.
Landry, P. Benaliouad, F. (2003). "Should Lipids be Monitored in the First Year of Treatment with an Atypical Antipsychotic?" Canadian Journal of Psychiatry 48: 348-349.
Landry, P., Benaliouad, F., et al. (2003). "Increased Use of Antibiotics in Clozapine-Treated Patients." International Journal of Psychopharmacology 18: 297-298.
Landry, P., Mainguy, N. (2003). "Conseils cliniques pour le sevrage des benzodiazépines." Santé Mentale du Québec 28: 43-58.
O’Connor, K. P., Marchand, A., Landry, P, et al. (2003). "Évaluation d'un programme d'aide au succès du sevrage des benzodiazépines." Revue Santé Mentale au Québec 28(2): 121-148.